1. Al-Barrak J, Cheung WY. Adherence to imatinib therapy in gastrointestinal stromal tumors and chronic myeloid leukemia. Support Care Cancer. 2013;21(8):2351–7.
2. Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, et al. NCCN task force report: oral chemotherapy. J Natl Compr Cancer Netw. 2008;6(Suppl 3):S1–14.
3. D’Amato SL. New oral chemotherapeutic agents: part B vs. part D implications. In: Association of Community Cancer Centers; 2008.
4. Geynisman DM, Wickersham KE. Adherence to targeted oral anticancer medications. Discov Med. 2013;15(83):231–41.
5. IMS Institute for Healthcare Informatics. Developments in cancer treatment, market dynamics, patient access and value: global oncology trend report 2015. In: QuintilesIMS Inc; 2015.